| Filed On | Filing |
|---|---|
| 13 Feb 2018 | SC 13G/A |
| 09 Feb 2018 | OMEGA PROTEIN CORPORATION |
| 09 Feb 2018 | SCHEDULE 13G/A |
| 02 Jan 2018 | FORM 15-12B |
| 29 Dec 2017 |
Form 3: Cooke Glenn, Director
No securities owned |
| 29 Dec 2017 |
Form 3: Butler Ross, Director
No securities owned |
| 22 Dec 2017 | FORM S-8 POS |
| 22 Dec 2017 | FORM S-8 POS |
| 22 Dec 2017 | FORM S-8 POS |
| 22 Dec 2017 | 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +6 more |
| 21 Dec 2017 |
Form 4: Held John D, See Remarks
Returned 68,472 shares to the issuer ($1.51M) |
| 21 Dec 2017 |
Form 4: Griffin Mark Edward, President - Animal Nutrition
Returned 77,277 shares to the issuer ($1.7M) |
| 21 Dec 2017 |
Form 4: Clark Celeste A., Director
Returned 3,374 shares to the issuer ($74.2K) |
| 21 Dec 2017 |
Form 4: Goodwin Gary R, Director
Returned 17,703 shares to the issuer ($389K) · Disposed of 20,000 Stock Options (right to buy) (Disposition to Issuer) ($241K) |
| 21 Dec 2017 |
Form 4: Johannesen Andrew, Executive VP and CFO
Returned 59,920 shares to the issuer ($1.32M) |
| 21 Dec 2017 |
Form 4: Christodolou Michael, Director
Returned 6,545 shares to the issuer ($144K) |
| 21 Dec 2017 |
Form 4: Deihl Montgomery, Vice President - Operations
Returned 23,103 shares to the issuer ($508K) |
| 21 Dec 2017 |
Form 4: Owen David Andrew, Director
Returned 26,531 shares to the issuer ($584K) · Disposed of 20,000 Stock Options (right to buy) (Disposition to Issuer) ($241K) |
| 21 Dec 2017 |
Form 4: Wehlmann David W, Director
Returned 17,901 shares to the issuer ($394K) · Disposed of 24,200 Stock Options (right to buy) (Disposition to Issuer) ($357K) |
| 21 Dec 2017 |
Form 4: Livingston Mark A, VP & Chief Accounting Officer
Returned 6,224 shares to the issuer ($137K) |
Loading...